Vascular disrupting agent DMXAA enhances the antitumor effects generated by therapeutic HPV DNA vaccines

Antigen-specific immunotherapy using DNA vaccines has emerged as an attractive approach for the control of tumors. Another novel cancer therapy involves the employment of the vascular disrupting agent, 5,6-dimethylxanthenone-4-acetic acid (DMXAA). In the current study, we aimed to test the combinati...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Shiwen, Monie, Archana, Pang, Xiaowu, Hung, Chien-Fu, Wu, T-C
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062584/
https://www.ncbi.nlm.nih.gov/pubmed/21385449
http://dx.doi.org/10.1186/1423-0127-18-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062584/
https://www.ncbi.nlm.nih.gov/pubmed/21385449
http://dx.doi.org/10.1186/1423-0127-18-21

Ejemplares similares